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In honor and memory of Theodore Millon (1928 – 2014) 
 
 
 
We are delighted to introduce this special issue of 
SJCAPP, which addresses personality disorders 
(PDs) in adolescence; financed through a generous 
grant from the Institute of Personality Theory and 
Psychopathology (IPTP) in Denmark. 
The International Society for the Study of 
Personality Disorders (ISSPD) was founded in 1988 
via the initiative of Theodore Millon, as we have 
described elsewhere (1). The purposes of the ISSPD 
were to establish international connections among 
people involved in the study of PDs and to foster 
collaboration for related research and education. 
The Danish IPTP served as the organizer of the 
first and founding ISSPD International Congress on 
the Study of Disorders of Personality, which was 
held in Copenhagen, Denmark, in 1988. The ISSPD 
has become the most prominent organization in the 
field of PD, and there has been rapid growth in 
research into PDs since its founding; this research 
has contributed significant findings that have altered 
our very understanding of the etiology, assessment, 
treatment, course, and outcome of PDs. 
From September 16 through 19, 2013, the XIIIth 
ISSPD Congress on the Disorders of Personality 
was organized by the IPTP and once again held in 
Copenhagen. A major reason for bringing the 
ISSPD Congress “back home” to Denmark was to 
celebrate the 25th anniversary of the ISSPD. The 
Congress had the overall theme of “Bridging 
Personality and Psychopathology: The Person 
Behind the Illness.” Ted Millon, the founding father 
of the ISSPD, served as patron of the Congress (2). 
The theme was chosen not only for its academic 
and clinical relevance but also as a salute to Millon, 
for whom this idea was a common thread 
throughout his pioneering and impressive career. 
Millon always insisted that personality, PD, and 
psychopathology were intermingled. He argued that 
they should be understood always as part and parcel 
of a complex and organically interwoven whole: the 
real person. With a voice that echoed the age-old 
Grecian thoughts of Hippocrates and later of Sir 
William Osler, Millon always insisted that we do not 
treat diagnoses but real people; our diagnostic 
categories only capture bits of this idea, and they 
leave out much of what is most important for 
treatment; namely, the very person behind the 
illness (3,4). This holistic and humanistic line of 
thinking advocated by Ted Millon has since been 
approved by the World Psychiatric Association 
(WPA) in the WPA Institutional Program on Psychiatry 
for the Person: From Clinical Care to Public Health in an 
effort to address the needs of real people and the 
inadequacies and fragmentation of mental health 
care and social services (5). This WPA initiative, 
which is also referred to person-centered psychiatry, 
affirms that it is the whole person of the patient—
within his or her context and at both the individual 
and community levels—that should be at the center 
of clinical care and health promotion (6). We should 
know our patients and take their personalities(-in-
context) into account whenever we conduct 
psychodiagnostic assessment or deliver treatment, 
whether it is psychosocial, pharmacological, or a 
mix of both. Knowing the personalities of our 
patients also means treating them as people, with 
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warmth and respect, and communicating effectively 
to serve their individual and social needs (7). In this 
respect, we suggest that knowing the person behind 
the illness is vital for the art of mental health care. 
This can be a curative factor in and of itself by 
fostering a working alliance and catalyzing hope, 
positive treatment expectations, and treatment 
adherence (8-11). 
Among the many presentations and areas covered 
by the XIIIth ISSPD Congress (12), deliberate 
privilege was given to the important issue of 
personality pathology in adolescence. After the 
Congress, the IPTP invited the authors of the 
excellent presentations about PD during 
adolescence to submit their work as articles for this 
special issue. We were fortunate to receive the seven 
scholarly papers that represent important 
contributions to this field. 
PD in adolescence has historically been regarded 
as controversial within the literature, and 
psychiatrists and clinical psychologists have been 
reluctant to diagnose PD during this stage of life. 
Although such controversy and hesitation were 
previously justified given the lack of empirical 
evidence, since the 1990s, research focusing on this 
subject has been steadily growing. Contrary to 
expectations, the accumulating empirical studies 
have converged to underscore the clinical 
importance and feasibility of detecting, diagnosing, 
and treating PD during adolescence. Thus, although 
articles about PD in childhood or adolescence 
customarily begin with somewhat apologetic, 
tentative, or defensive statements, we shall refrain 
from this practice. We agree with Tackett and Sharp 
(13) that, in light of the available evidence, such 
statements are no longer needed. PDs are 
developmental disorders that should accordingly be 
approached and understood from a lifespan 
developmental perspective (14,15), and we will 
expand on this idea in the concluding article for this 
special issue (16). This developmental conception of 
PD is also recognized within the official diagnostic 
systems of the Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition (DSM-5) (17) and the 
International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision (ICD-10) (18), 
which both allow for the diagnosis of PD in 
individuals who are less than 18 years old (except 
for antisocial PD, which the DSM-5, Section II, 
does not allow for diagnosing before the age of 18). 
The upcoming ICD-11 will in all likelihood 
continue to endorse this idea by removing any 
arbitrary age restrictions for PD diagnosis, as was 
done for the DSM-5 Section III alternative 
classification of PD. 
Another important reason for the increasing 
interest in PD during adolescence is the likelihood 
that the earlier the illness starts, the more likely it is 
to become severe and chronic. Indeed—albeit 
arguably—we firmly believe that prevention and 
early intervention lie at the heart of all of the clinical 
sciences. Given that PDs are developmental 
disorders that usually emerge during childhood or 
adolescence, as has been convincingly argued by 
Chanen and colleagues (19,20), prevention and early 
intervention for PDs ought to be given high priority 
in the future. This confers a privileged position to 
the fields of child and adolescent psychiatry and 
psychology, in which interventions can be delivered 
at an early age to target key PD symptoms, perhaps 
before such symptoms become more entrenched 
and possibly chronic. 
With these reflections in mind, it came as no 
surprise that the validity of the borderline PD 
diagnosis was the focus of many of the articles 
included in this special issue. Fossati (21) tackles 
this issue head on with his review of the empirical 
literature regarding the feasibility of diagnosing 
borderline PD during adolescence. He argues that 
research in adults with borderline PD has revealed 
and paved the way for global interest in early 
identification and intervention. The interrater 
reliability and internal consistency of the adolescent 
borderline PD construct seems adequate. Reliable 
and valid measures of borderline PD during 
adolescence are also available. Fossati furthermore 
reports that although no single diagnostic symptom 
is predictive of future borderline PD diagnosis, 
combinations of two or more borderline PD 
symptoms are. Links between borderline PD and 
disruptive behavior disorders such as attention-
deficit/hyperactivity disorder (ADHD) are also 
discussed. In this SJCAPP special issue, Sharp and 
Kalpakci (22) also focus on the validity of the 
borderline PD construct for adolescents by using 
the five classic validation criteria of Robins and 
Guze. Like Fossati, these authors conclude that the 
available evidence supports the construct validity of 
borderline PD diagnosis during adolescence, 
although there are problems with the delimitation 
from other psychiatric disorders. Moreover, they 
point to the fact that there is only a limited number 
of family and longitudinal studies. They conclude by 
suggesting that, in the future, the validity of the 
borderline PD construct should be investigated with 
the use of the National Institute of Mental Health 
developed Research Domain Criteria (RDoC) as a 
complement, which propagate a dimensional system 
in response to the flawed categorical system. 
Brunner, Henze, Richter, and Kaess (23), in this 
issue, summarize the neurobiological research on 
borderline PD in youth. They argue for the 
importance of this line of research during 
adolescence, when potential confounding factors 
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are less likely to be present. The authors focus on 
recent research within the field and review results 
that pertain to genetics, neuroimaging, 
neuropsychology, endocrinology, and disturbed 
pain perception; they then integrate their findings 
into a developmental psychopathological model. 
They also underline the need for future longitudinal 
studies to help determine whether neurobiological 
factors are a cause, an effect, or an epiphenomenon 
of borderline PD. 
The article by Schlüter-Müller, Goth, Jung, and 
Schmeck (24) provides yet another perspective on 
PD in adolescence generally and on borderline PD 
more specifically by focusing on identity pathology. 
They describe the psychometric properties of the 
Assessment of Identity Development in 
Adolescence (AIDA), a newly developed self-report 
inventory for the assessment of identity pathology 
during adolescence. They also outline a treatment 
model inspired by psychodynamic object relations 
theory including the Kernberg group’s transference-
focused therapy (25,26). 
The next two articles in this issue take an 
alternative approach by focusing on the 
psychometric evaluation of assessment instruments 
for maladaptive personality traits in adolescent 
samples. Tromp and Koot (27) describe the 
factorial structure, reliability, and validity of the 
Dimensional Assessment of Personality Pathology – 
Short Form for Adolescents (DAPP-SF-A), 
demonstrating its potential utility in both research 
and applied settings as a brief measure of 
maladaptive personality traits to enable routine 
clinical assessments as well as future research into 
the developmental trajectories of PDs throughout 
the lifespan. The article by Kongerslev, Bo, Forth, 
and Simonsen (28) focuses on examining the 
psychometric properties of the Inventory of 
Callous-Unemotional Traits (ICU). This study 
provides preliminary support for the psychometric 
adequacy of the Danish version of the ICU in a 
sample of incarcerated adolescent boys, as weel as 
the construct of callous-unemotional traits strong 
association with the broader concept of 
psychopathy. With the inclusion of callous-
unemotional traits in the DSM-5 as well as the 
addition of a “with limited prosocial emotions” 
specifier for the diagnosis of conduct disorder, we 
expect that much more research will be generated in 
the future regarding this maladaptive trait–based 
subtyping of the heterogenous and behaviorally 
based construct of conduct disorder. 
To conclude this special issue of SJCAPP and to 
broaden its scope beyond specific PDs and 
approaches, we—together with Andrew M. 
Chanen—provide a narrative review of the available 
research evidence for PDs during childhood and 
adolescence (16). We are grateful to have Dr. 
Chanen, who is the current president of the ISSPD 
and widely regarded as a leading expert on 
prevention and early intervention for PDs during 
adolescence, as part of our author team. 
With this special issue, we hope to further the 
research agenda regarding PD in adolescence and to 
draw clinicians’ attention to the feasibility and 
importance of diagnosing and treating PD during 
childhood and adolescence. We want to thank all of 
the contributing authors for submitting their articles 
to SJCAPP, and we wholeheartedly dedicate this 
special issue to Ted Millon, who paved the way. 
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